![Tony Wood tritt die Nachfolge von Dr. Hal Barron als Chief Scientific Officer bei GlaxoSmithKline R&D an | EuropaWire.eu | The European Union's press release distribution & newswire service Tony Wood tritt die Nachfolge von Dr. Hal Barron als Chief Scientific Officer bei GlaxoSmithKline R&D an | EuropaWire.eu | The European Union's press release distribution & newswire service](https://news.europawire.eu/wp-content/uploads/2022/01/TONY-WOOD-GSK-1280x720.jpg)
Tony Wood tritt die Nachfolge von Dr. Hal Barron als Chief Scientific Officer bei GlaxoSmithKline R&D an | EuropaWire.eu | The European Union's press release distribution & newswire service
Olivier MALAGUTI – Warehouse Team Leader at GSK - First Line Leader – GSK, Novartis Consumer Health | LinkedIn
![GSK-3 phosphorylates Ser 468 of p65 in vitro. A, recombinant GSK-3 and... | Download Scientific Diagram GSK-3 phosphorylates Ser 468 of p65 in vitro. A, recombinant GSK-3 and... | Download Scientific Diagram](https://www.researchgate.net/publication/8249480/figure/fig2/AS:394474019672067@1471061343909/GSK-3-phosphorylates-Ser-468-of-p65-in-vitro-A-recombinant-GSK-3-and-GST-p65-354-551.png)